CNBX Pharmaceuticals Inc
cnbxpharma.comWhat Do They Do?
Develops cannabinoid-based drug candidates and technologies for cancer treatment, including Cannabics SR for cancer-related appetite and weight loss and a colorectal cancer drug candidate.
10-K for FY2025, filed Dec 1, 2025We are a clinical-stage company specializing in the discovery, development and commercialization of novel cannabinoid-based products and…View ↗
Our first lead product candidate is Cannabics SR the oral capsule developed for the treatment of patients with advanced cancer and cancer…View ↗
CNBX Pharmaceuticals Inc. is a clinical stage pharmaceutical company primarily focused on the development of novel cannabinoid-based…View ↗
How Are They Changing?
Who Do They Compete With?
Competes with GW Pharmaceuticals, Cannabis Science, InMed Pharmaceuticals, Emerald Bioscience, Corbus Pharmaceuticals Holdings, Zynerba Pharmaceuticals, PharmaCyte Biotech, Tetra Bio-Pharma, and Cure Pharmaceutical Holding
10-K for FY2025, filed Dec 1, 2025As the medical use of cannabis increasingly receives government approval worldwide, we face growing competition from many new and existing…View ↗
Loading...
